A composite XPD genotype made of Asn at codon 312 and Gln at codon 751 of the XPD gene may be associated with poorer response to chemotherapy and decreased overall survival in advanced non-small-cell lung cancer (7). This evidence concerns the gene ERCC2 and non-small cell lung carcinoma.